Atlas Trials

Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia

Clinical trial NCT00138736 · COMPLETED

Trial details

NCT number
NCT00138736
Sponsor
Prothya Biosolutions
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
MBL-DeficientNeutropenia
Start date
2004-04-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.